Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
Clinical trial NCT01236573 · TERMINATED
Trial details
- NCT number
- NCT01236573
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2015-03-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.